Meeting Report: Global Forecasts of Antiretroviral Demand for 2014-2018 and Projection Modelling of New Antitretroviral Formulations for 2015–2024 and Update on Hepatitis B and C

The World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) Secretariat organize an annual meeting with pharmaceutical companies and stakeholders to discuss antiretroviral (ARV) drug demand forecasts for adults and children.

The March 2015 meeting went beyond the usual three-year forecast by including a model of new ARVs that will be needed up to 2024. For the first time this year, the meeting also included a discussion on hepatitis B and C medicines.